Diagnostic value of PCR analysis of bacteria and fungi from blood in empiric-therapy-resistant febrile neutropenia

Journal of Clinical Microbiology

Volumn 48, Issue 6, 2010, Pages 2030-2036

  Nakamura, Akiko ^a   Sugimoto, Yuka ^b   Ohishi, Kohshi ^a   Sugawara, Yumiko ^b   Fujieda, Atsushi ^b   Monma, Fumihiko ^b   Suzuki, Kei ^b   Masuya, Masahiro ^b   Nakase, Kazunori ^a   Matsushima, Yoshiko ^a   Wada, Hideo ^a   Katayama, Naoyuki ^b   Nobori, Tsutomu ^a  

^a MIE UNIVERSITY HOSPITAL   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ENOCITABINE; ETOPOSIDE; FLUDARABINE; FOSFLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; HABEKACIN; ITRACONAZOLE; LEVOFLOXACIN; MELPHALAN; MEROPENEM; MINOCYCLINE; MITOXANTRONE; PAZUFLOXACIN; TEICOPLANIN; VINCRISTINE; VINDESINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD ANALYSIS; BLOOD CULTURE; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CITROBACTER FREUNDII; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DIAGNOSTIC VALUE; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HUMAN; MALE; MYCOSIS; MYELODYSPLASTIC SYNDROME; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS SALIVARIUS; WHOLE BODY RADIATION;

ADULT; AGED; ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; BACTERIAL INFECTIONS; BLOOD; DRUG THERAPY; FEMALE; FEVER OF UNKNOWN ORIGIN; FUNGI; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MYCOSES; NEUTROPENIA; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; YOUNG ADULT;

ASPERGILLUS FUMIGATUS; FUNGI; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

EID: 77952911066     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01700-09     Document Type: Article

References (40)

1. Almyroudis, N. G., and B. H. Segal. 2009. Prevention and treatment of invasive fungal diseases in neutropenic patients. Curr. Opin. Infect. Dis. 22:385-393.
2. Badiee, P., P. Kordbacheh, A. Alborzi, M. Ramzi, and E. Shakiba. 2008. Molecular detection of invasive aspergillosis in hematologic malignancies. Infection 36:580-584.
3. Bal, A. M., and I. M. Gould. 2007. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia. Int. J. Antimicrob. Agents 29: 501-509.
4. Balajee, S. A., A. M. Borman, M. E. Brandt, J. Cano, M. Cuenca-Estrella, E. Dannaoui, J. Guarro, G. Haase, C. C. Kibbler, W. Meyer, K. O'Donnell, C. A. Petti, J. L. Rodriguez-Tudela, D. Sutton, A. Velegraki, and B. L. Wickes. 2009. Sequence-based identification of Aspergillus, Fusarium, and Mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J. Clin. Microbiol. 47:877-884.
5. Bodey, G. P., L. Jadeja, and L. Elting. 1985. Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch. Intern. Med. 145:1621-1629.
6. Carmeli, Y. 2008. Strategies for managing today's infections. Clin. Microbiol. Infect. 14(Suppl. 3):22-31.
7. Cuenca-Estrella, M., Y. Meije, C. Diaz-Pedroche, A. Gomez-Lopez, M. J. Buitrago, L. Bernal-Martinez, C. Grande, R. S. Juan, M. Lizasoain, J. L. Rodriguez-Tudela, and J. M. Aguado. 2009. Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive aspergillosis in patients with febrile neutropenia. J. Clin. Microbiol. 47:379-384.
8. De Pauw, B., T. J. Walsh, J. P. Donnelly, D. A. Stevens, J. E. Edwards, T. Calandra, P. G. Pappas, J. Maertens, O. Lortholary, C. A. Kauffman, D. W. Denning, T. F. Patterson, G. Maschmeyer, J. Bille, W. E. Dismukes, R. Herbrecht, W. W. Hope, C. C. Kibbler, B. J. Kullberg, K. A. Marr, P. Munoz, F. C. Odds, J. R. Perfect, A. Restrepo, M. Ruhnke, B. H. Segal, J. D. Sobel, T. C. Sorrell, C. Viscoli, J. R. Wingard, T. Zaoutis, and J. E. Bennett. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
9. Einsele, H., and J. Loeffler. 2008. Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients. Clin. Microbiol. Infect. 14(Suppl. 4):37-45.
10. El-Mahallawy, H. A., H. H. Shaker, H. Ali Helmy, T. Mostafa, and A. Razak Abo-Sedah. 2006. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients. Med. Mycol. 44:733-739.
11. Falagas, M. E., P. E. Valkimadi, Y. T. Huang, D. K. Matthaiou, and P. R. Hsueh. 2008. Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J. Antimicrob. Chemother. 62:889-894.
12. Halliday, C., R. Hoile, T. Sorrell, G. James, S. Yadav, P. Shaw, M. Bleakley, K. Bradstock, and S. Chen. 2006. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. Br. J. Haematol. 132:478-486.
13. Hebart, H., J. Loffler, H. Reitze, A. Engel, U. Schumacher, T. Klingebiel, P. Bader, A. Bohme, H. Martin, D. Bunjes, W. V. Kern, L. Kanz, and H. Einsele. 2000. Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia. Br. J. Haematol. 111:635-640.
14. Hughes, W. T., D. Armstrong, G. P. Bodey, E. J. Bow, A. E. Brown, T. Calandra, R. Feld, P. A. Pizzo, K. V. Rolston, J. L. Shenep, and L. S. Young. 2002. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis. 34:730-751.
15. Kami, M., T. Fukui, S. Ogawa, Y. Kazuyama, U. Machida, Y. Tanaka, Y. Kanda, T. Kashima, Y. Yamazaki, T. Hamaki, S. Mori, H. Akiyama, Y. Mutou, H. Sakamaki, K. Osumi, S. Kimura, and H. Hirai. 2001. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin. Infect. Dis. 33:1504-1512.
16. Lehmann, L. E., K. P. Hunfeld, T. Emrich, G. Haberhausen, H. Wissing, A. Hoeft, and F. Stuber. 2008. A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med. Microbiol. Immunol. 197:313-324.
17. Lo, N., and M. Cullen. 2006. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider. Hematol. Oncol. 24:120-125.
18. Lode, H. 2005. Management of serious nosocomial bacterial infections: do current therapeutic options meet the need? Clin. Microbiol. Infect. 11:778-787.
19. Mancini, N., D. Clerici, R. Diotti, M. Perotti, N. Ghidoli, D. De Marco, B. Pizzorno, T. Emrich, R. Burioni, F. Ciceri, and M. Clementi. 2008. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J. Med. Microbiol. 57:601-604.
20. Marchetti, O., and T. Calandra. 2002. Infections in neutropenic cancer patients. Lancet 359:723-725.
21. Maschmeyer, G., T. Beinert, D. Buchheidt, O. A. Cornely, H. Einsele, W. Heinz, C. P. Heussel, C. Kahl, M. Kiehl, J. Lorenz, H. Hof, and G. Mattiuzzi. 2009. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the infectious diseases working party of the German Society of Haematology and Oncology. Eur. J. Cancer 45:2462-2472.
22. Mengoli, C., M. Cruciani, R. A. Barnes, J. Loeffler, and J. P. Donnelly. 2009. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect. Dis. 9:89-96.
23. Middleman, E. L., A. Watanabe, H. Kaizer, and G. P. Bodey. 1972. Antibiotic combinations for infections in neutropenic patients. Evaluaton of carbenicillin plus either cephalothin or kanamycin. Cancer 30:573-579.
24. Nakamura, A., H. Wada, M. Ikejiri, T. Hatada, H. Sakurai, Y. Matsushima, J. Nishioka, K. Maruyama, S. Isaji, T. Takeda, and T. Nobori. 2009. Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit. Shock 31:586-591.
25. Nicodemo, A. C., and J. I. Paez. 2007. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur. J. Clin. Microbiol. Infect. Dis. 26:229-237.
26. Pascoe, J., and N. Steven. 2009. Antibiotics for the prevention of febrile neutropenia. Curr. Opin. Hematol. 16:48-52.
27. Perlin, D. S., and Y. Zhao. 2009. Molecular diagnostic platforms for detecting Aspergillus. Med. Mycol. 47(Suppl. 1):S223-S232.
28. Pizzo, P. A. 1993. Management of fever in patients with cancer and treatment-induced neutropenia. N. Engl. J. Med. 328:1323-1332.
29. Raad, I., H. Hanna, D. Sumoza, and M. Albitar. 2002. Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients. Cancer 94:1032-1036. (Pubitemid 34150858)
30. Rolston, K. V. 2004. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments. Clin. Infect. Dis. 39(Suppl. 1):S44-S48.
31. Safdar, A., and K. V. Rolston. 2007. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin. Infect. Dis. 45:1602-1609.
32. Schimpff, S., W. Satterlee, V. M. Young, and A. Serpick. 1971. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N. Engl. J. Med. 284:1061-1065.
33. Serody, J. S., M. M. Berrey, K. Albritton, S. M. O'Brien, E. P. Capel, S. H. Bigelow, D. J. Weber, D. A. Gabriel, J. M. Wiley, M. J. Schell, P. H. Gilligan, and T. C. Shea. 2000. Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant. 26:533-538.
34. Sipsas, N. V., G. P. Bodey, and D. P. Kontoyiannis. 2005. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer 103:1103-1113. (Pubitemid 40328079)
35. Spiess, B., W. Seifarth, M. Hummel, O. Frank, A. Fabarius, C. Zheng, H. Morz, R. Hehlmann, and D. Buchheidt. 2007. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J. Clin. Microbiol. 45:3743-3753.
36. Tanabe, M., H. Nakajima, A. Nakamura, T. Ito, M. Nakamura, T. Shimono, H. Wada, H. Shimpo, T. Nobori, and M. Ito. 2009. Mycotic aortic aneurysm associated with Legionella anisa. J. Clin. Microbiol. 47:2340-2343.
37. von Lilienfeld-Toal, M., L. E. Lehmann, A. D. Raadts, C. Hahn-Ast, K. S. Orlopp, G. Marklein, I. Purr, G. Cook, A. Hoeft, A. Glasmacher, and F. Stuber. 2009. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J. Clin. Microbiol. 47:2405-2410.
38. Wellinghausen, N., A. J. Kochem, C. Disque, H. Muhl, S. Gebert, J. Winter, J. Matten, and S. G. Sakka. 2009. Diagnosis of bacteremia in whole blood samples by a commercial universal 16S rDNA-based PCR and sequence analysis. J. Clin. Microbiol. 47:2759-2765.
39. Westh, H., G. Lisby, F. Breysse, B. Boddinghaus, M. Chomarat, V. Gant, A. Goglio, A. Raglio, H. Schuster, F. Stuber, H. Wissing, and A. Hoeft. 2009. Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin. Microbiol. Infect. 15:544-551.
40. Xu, J., J. E. Moore, B. C. Millar, H. D. Alexander, R. McClurg, T. C. Morris, and P. J. Rooney. 2004. Improved laboratory diagnosis of bacterial and fungal infections in patients with hematological malignancies using PCR and ribosomal RNA sequence analysis. Leuk. Lymphoma 45:1637-1641. (Pubitemid 38886009)